Aprotinin, a kallikrein inhibitor, is currently being investigated for treatment of chronic parotitis symptoms. Initial studies have demonstrated its potential to relieve pain, restore normal parotid gland function, and resolve parotid gland swelling. Further research is warranted.
Parotitis future or investigational therapies
Parotitis primary prevention
Endometrial cancer medical therapy
Cystitis future or investigational therapies
Prostatitis echocardiorgaphy and ultrasound
Deep vein thrombosis future or investigational therapies
Parotitis CT or MRI
Proctitis medical therapy